Risk Factors for Acute Kidney Injury in Diabetic Patients

Status Not yet recruiting

Clinical Trial Summary

incidence of AKI in diabetic patients seems to be influenced by multiple risk Factors like severe infections, elderly, poor diabetic control, previous AKI, chronic kidney disease and drugs like SGLT2-I increase risk of AKI in diabetic patients.

Clinical Trial Description

The incidence and prevalence of diabetes mellitus (DM) have increased over the last 20 years. The defining feature of diabetes mellitus (DM) is the presence of hyperglycaemia . mostly due to the progressively increasing prevalence of obesity and the metabolic syndrome, Current prevalence of DM worldwide is estimated to be about 390 million people . The Cardiovascular complications increase morbidity and mortality in diabetic patients. About 40% of end-stage renal disease on regular dialysis are diabetic . Acute kidney injury (AKI) Is a fundamental problem in hospitalized patients; its incidence has been reaching 20% in middle-Europe . About 50% of patients presented with AKI are found to be diabetic ; which may indicate a direct relationship between the two conditions. In 2012, a clinical practice guideline published by Kidney Disease: Improving Global Outcomes (KDIGO) provided a unifying definition and staging system for AKI . On the other hand, incidence of AKI in diabetic patients seems to be influenced by multiple risk Factors like severe infections, elderly, poor diabetic control, previous AKI, chronic kidney disease and drugs like SGLT2-I increase risk of AKI in diabetic patients. We aim in this study to identify the most common risk factors for AKI in diabetic patients and how those risk factors affect morbidity and mortality in patients with DM who developed AKI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05147818
Study type	Observational
Source	Assiut University
Contact
Status	Not yet recruiting
Phase
Start date	December 1, 2021
Completion date	December 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05563090` - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Recruiting	`NCT05333159` - The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
Active, not recruiting	`NCT03119584` - Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation	Phase 4
Completed	`NCT04409171` - Glucose Metabolism After Partial Pancreatectomy
Recruiting	`NCT06060392` - Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus	N/A
Completed	`NCT05144971` - StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
Completed	`NCT03914183` - Can mCPN Intervention Improve Injection Site Rotation	N/A
Completed	`NCT03781232` - Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes	N/A
Not yet recruiting	`NCT06150508` - Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health	N/A
Completed	`NCT01252810` - Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure	Phase 2
Active, not recruiting	`NCT04171557` - Bicycling and Mortality Among Individuals With diabetesNutrition (EPIC)
Active, not recruiting	`NCT03155594` - CGM to Aid Transition From Inpatient to Outpatient	N/A
Not yet recruiting	`NCT06358118` - Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders	N/A
Completed	`NCT04864327` - Smoking Intervention Among Patients With Diabetes	N/A
Completed	`NCT04407182` - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19	Phase 2
Completed	`NCT05752591` - Hypothalamic-pituitary Dysfunction in Diabetes
Completed	`NCT03159546` - FreeStyle Libre Flash Glucose Monitoring System Accuracy	N/A
Completed	`NCT03953092` - A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699	Phase 1
Not yet recruiting	`NCT06262854` - Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study	N/A
Completed	`NCT03934281` - Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient	N/A